112 related articles for article (PubMed ID: 26966912)
1. Rhinosinusal Inflammation and High Mobility Group Box 1 Protein: A New Target for Therapy.
Bellussi LM; Cocca S; Chen L; Passali FM; Sarafoleanu C; Passali D
ORL J Otorhinolaryngol Relat Spec; 2016; 78(2):77-85. PubMed ID: 26966912
[TBL] [Abstract][Full Text] [Related]
2. Agonist of PPAR-γ Reduced Epithelial-Mesenchymal Transition in Eosinophilic Chronic Rhinosinusitis with Nasal Polyps via Inhibition of High Mobility Group Box1.
Yang P; Chen S; Zhong G; Kong W; Wang Y
Int J Med Sci; 2019; 16(12):1631-1641. PubMed ID: 31839751
[TBL] [Abstract][Full Text] [Related]
3. Increase of high mobility group box chromosomal protein 1 in eosinophilic chronic rhinosinusitis with nasal polyps.
Chen D; Mao M; Bellussi LM; Passali D; Chen L
Int Forum Allergy Rhinol; 2014 Jun; 4(6):453-62. PubMed ID: 24504744
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of high-mobility group protein B1 in chronic rhinosinusitis.
Hong SM; Cho JS; Um JY; Shin JM; Park IH; Lee SH; Lee SH; Lee HM
Am J Rhinol Allergy; 2013; 27(4):278-82. PubMed ID: 23883808
[TBL] [Abstract][Full Text] [Related]
5. Level of secreted HMGB1 correlates with severity of inflammation in chronic rhinosinusitis.
Min HJ; Kim SJ; Kim TH; Chung HJ; Yoon JH; Kim CH
Laryngoscope; 2015 Jul; 125(7):E225-30. PubMed ID: 25639490
[TBL] [Abstract][Full Text] [Related]
6. Are HMGB1 protein expression and secretion markers of upper airways inflammatory diseases?
Bellussi LM; Iosif C; Sarafoleanu C; Jianu E; Duda R; Panaitescu E; Passali FM; Passali D
J Biol Regul Homeost Agents; 2013; 27(3):791-804. PubMed ID: 24152844
[TBL] [Abstract][Full Text] [Related]
7. LPS may enhance expression and release of HMGB1 in human nasal epithelial cells in vitro.
Chen D; Bellussi LM; Passali D; Chen L
Acta Otorhinolaryngol Ital; 2013 Dec; 33(6):398-404. PubMed ID: 24376296
[TBL] [Abstract][Full Text] [Related]
8. Glycyrrhetinic acid suppressed hmgb1 release by up-regulation of Sirt6 in nasal inflammation.
Chen D; Bellussi LM; Cocca S; Wang J; Passali GC; Hao X; Chen L; Passali D
J Biol Regul Homeost Agents; 2017; 31(2):269-277. PubMed ID: 28685526
[TBL] [Abstract][Full Text] [Related]
9. Ethyl pyruvate ameliorate inflammatory response of sinonasal mucosa by inhibiting HMGB1 in rats with acute rhinosinusitis.
Liang X; Shen Y; Zhang X; He G; Tan G
Sci Rep; 2021 Mar; 11(1):6206. PubMed ID: 33737667
[TBL] [Abstract][Full Text] [Related]
10. HMGB1 in the Pathogenesis of Nasal Inflammatory Diseases and its Inhibition as New Therapeutic Approach: A Review from the Literature.
Bellussi LM; Cocca S; Passali GC; Passali D
Int Arch Otorhinolaryngol; 2017 Oct; 21(4):390-398. PubMed ID: 29018504
[No Abstract] [Full Text] [Related]
11. HMGB1 in nasal inflammatory diseases: a reappraisal 30 years after its discovery.
Ciprandi G; Bellussi LM; Passali GC; Damiani V; Passali D
Expert Rev Clin Immunol; 2020 May; 16(5):457-463. PubMed ID: 32252560
[TBL] [Abstract][Full Text] [Related]
12. From Genesis to Revelation: The Role of Inflammatory Mediators in Chronic Respiratory Diseases and their Control by Nucleic Acid-based Drugs.
Gioia SD; Sardo C; Castellani S; Porsio B; Belgiovine G; Carbone A; Giammona G; Cavallaro G; Conese M
Curr Drug Deliv; 2017; 14(2):253-271. PubMed ID: 27557670
[TBL] [Abstract][Full Text] [Related]
13. IL-25 as a novel therapeutic target in nasal polyps of patients with chronic rhinosinusitis.
Shin HW; Kim DK; Park MH; Eun KM; Lee M; So D; Kong IG; Mo JH; Yang MS; Jin HR; Park JW; Kim DW
J Allergy Clin Immunol; 2015 Jun; 135(6):1476-85.e7. PubMed ID: 25725991
[TBL] [Abstract][Full Text] [Related]
14. High motility group box 1 (HMGB1) protein and its receptor for advanced glycation end products (RAGE) expression in chronic rhinosinusitis without nasal polyps.
Dzaman K; Zagor M; Molinska-Glura M; Krzeski A
Folia Histochem Cytobiol; 2015; 53(1):70-8. PubMed ID: 25772690
[TBL] [Abstract][Full Text] [Related]
15. Targeting high mobility group box protein 1 ameliorates testicular inflammation in experimental autoimmune orchitis.
Aslani F; Schuppe HC; Guazzone VA; Bhushan S; Wahle E; Lochnit G; Lustig L; Meinhardt A; Fijak M
Hum Reprod; 2015 Feb; 30(2):417-31. PubMed ID: 25452436
[TBL] [Abstract][Full Text] [Related]
16. The role of intracellular high-mobility group box 1 in the early activation of Kupffer cells and the development of Con A-induced acute liver failure.
Yang Q; Liu Y; Shi Y; Zheng M; He J; Chen Z
Immunobiology; 2013 Oct; 218(10):1284-92. PubMed ID: 23706499
[TBL] [Abstract][Full Text] [Related]
17. High-mobility group box 1 protein induces epithelialmesenchymal transition in upper airway epithelial cells.
Min HJ; Choe JW; Kim KS; Yoon JH; Kim CH
Rhinology; 2020 Oct; 58(5):495-505. PubMed ID: 32478338
[TBL] [Abstract][Full Text] [Related]
18. ROS-dependent HMGB1 secretion upregulates IL-8 in upper airway epithelial cells under hypoxic condition.
Min HJ; Kim JH; Yoo JE; Oh JH; Kim KS; Yoon JH; Kim CH
Mucosal Immunol; 2017 May; 10(3):685-694. PubMed ID: 27624778
[TBL] [Abstract][Full Text] [Related]
19. Expression of IL-33 and its receptor ST2 in chronic rhinosinusitis with nasal polyps.
Baba S; Kondo K; Kanaya K; Suzukawa K; Ushio M; Urata S; Asakage T; Kakigi A; Suzukawa M; Ohta K; Yamasoba T
Laryngoscope; 2014 Apr; 124(4):E115-22. PubMed ID: 24122812
[TBL] [Abstract][Full Text] [Related]
20. High-mobility-group box protein 1A box reduces development of sodium laurate-induced thromboangiitis obliterans in rats.
Kong X; Yuan H; Wu X; Zhang J; Zhou H; Wang M; Liu Y; Jin X
J Vasc Surg; 2013 Jan; 57(1):194-204. PubMed ID: 23069071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
